News article 7
Fremantle is becoming an emerging hub for biotech investments and activities in Western Australia.
One significant event is the 18th Bioshares Biotech Summit, which will be held at the Esplanade Hotel in Fremantle in July 2024. This summit will bring together biotech companies, investors, and service providers to build stronger connections and explore new opportunities in the biotech sector. The event is supported by the WA State Government and features a variety of sponsors, including IP firm FB Rice, law firm Piper Alderman, and ASX, among others BioShares Labiotech.eu.
Additionally, the 2024 Bioshares Biotech Summit will feature presentations from several notable biotech companies such as Telix Pharmaceuticals, Neuren Pharmaceuticals, Clinuvel Pharmaceuticals, and PYC Therapeutics. This indicates a growing interest and investment in the biotech industry within Fremantle and the broader Western Australian region (BioShares) (Labiotech.eu).
These activities and investments signify Fremantle's rising importance as a biotech hub, attracting both local and international attention to its expanding capabilities in this sector.
